Senior Director, Digital Innovation at Definium Therapeutics

Job description

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges. Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today’s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX. Together we are moving psychiatry forward—beyond better, into a boundless future. Join us! As the company grows, we are building the digital capabilities, data foundation, and operating model needed to support development, launch readiness, and future commercialization. The Senior Director, Digital Innovation will serve as a strategic bridge between Enterprise Technology and the business, translating needs across Clinical, Commercial, Medical Affairs, Market Access, Patient Services, Finance, and Corporate functions into a pragmatic digital roadmap. This is not simply a technology delivery role. The successful leader will help Definium determine where digital, data, automation, and AI can create meaningful business value, then orchestrate the people, platforms, vendors, governance, and change required to deliver it. What You’ll Do Set the Digital Strategy & Roadmap Partner with business and technology leaders to define an enterprise digital innovation strategy aligned with Definium’s 3-5 year growth and commercialization plans. Assess current digital capabilities, platforms, vendors, consultants, AI initiatives, and spend; identify gaps, overlap, underutilized capabilities, and opportunities to simplify. Build and maintain a prioritized multi-year roadmap that sequences investments based on business value, readiness, risk, and scalability. Continuously benchmark emerging practices across biotech, specialty pharma, and adjacent industries, separating durable opportunities from technology hype. Enable Commercial & Patient-Focused Capabilities Partner with Commercial, Market Access, Patient Services, Medical Affairs, and Enterprise Technology to define capabilities required for launch readiness and post-launch operations. Help shape the future digital patient and provider experience, including capabilities supporting patient services, reimbursement, engagement, adherence, and omnichannel interactions. Partner with data and functional leaders to strengthen analytics and decision support so leadership can effectively manage the business as commercialization approaches. Advance Responsible AI & Automation Identify high-value opportunities to apply AI, automation, and emerging digital capabilities across the enterprise. Create a practical intake and prioritization approach for experimentation and scaled adoption, with clear business ownership and measurable outcomes. Partner with Enterprise Technology, Legal, Compliance, Privacy, and business stakeholders to promote responsible, secure, and sustainable adoption of new capabilities. Build the Operating Model Clarify decision rights and responsibilities across Enterprise Technology, Digital Innovation, and functional teams so solutions have clear ownership from idea through adoption and